The AI Learning Hub Journal

Local Validation Is a Requirement

Why a model has to be revalidated where it will be usedfour things change on the way in, and each of them moves the behaviourA model validated somewhere elsestrong published results, on their dataPopulation mixDifferent ages, conditionsand referral routes from thegroup it was validated on.Equipment and inputsDifferent scanners, settings,assays and record systemsproduce different inputs.WorkflowWhere it sits in the pathwaychanges who sees the outputand what happens next.PrevalenceHow common the condition ishere changes what a flag isworth to whoever reads it.LOCAL VALIDATION — ON YOUR OWN DATA, IN YOUR OWN SETTINGA local samplerepresentative of who you seeA pre-agreed barset before you look at resultsA named ownerwho can say no to go-liveA written recordof what was checked and howAPPROVED FOR LOCAL USEwith the scope written downHELD BACK OR NARROWEDuntil it works here tooThen it keeps being checked — populations drift, equipment changes, workflows quietly movePerformance is a property of a model in a place, not a property of the model
Published performance travels with the setting it was measured in — not with the model file

Why External Evidence Is Not Enough

Everything covered so far converges here. Operating points depend on prevalence, which is local. Acquisition signatures depend on equipment, which is local. Population characteristics, case mix, referral patterns, coding conventions, documentation habits, and data completeness are all local. A model validated elsewhere, however well, has demonstrated that it can work — not that it works here. Local validation is the step that converts a general capability claim into institution-specific evidence, and it is the step most often skipped under time pressure, precisely because external evidence looks reassuring. Treating it as a compliance formality rather than the load-bearing evidence for your deployment is the most common serious mistake in healthcare AI adoption.

  • Prevalence, equipment, case mix, coding, and data completeness are all local variables
  • External evidence shows the model can work, not that it works in your setting
  • Local validation is the load-bearing evidence for your deployment, not a formality

What It Involves in Practice

A workable local validation needs a representative sample of your own cases with reliable reference labels, evaluation against a defined comparator that reflects current practice, performance reported by relevant subgroup rather than in aggregate, and an assessment of how the tool behaves on the messy inputs your systems actually produce — missing fields, unusual formats, out-of-scope cases. Silent or shadow mode is often the practical route: the tool runs on live data and its outputs are recorded but not shown to clinicians, so you observe real-world behaviour without exposing patients to it. This costs time and clinical effort. Institutions that treat that cost as part of the purchase price make better decisions than those that treat it as overhead.

  • Representative local sample, reliable reference labels, and a comparator reflecting current practice
  • Report by subgroup, and include the messy and out-of-scope inputs your systems really produce
  • Silent or shadow mode observes live behaviour without exposing patients to the output
  • Budget validation effort as part of the acquisition cost, not as overhead

Pre-Commit to the Stop Rule

Decide what result would mean you do not proceed, and write it down before the data arrives. This is the single highest-value governance step available, and it is cheap. Without a pre-specified rule, disappointing results get reinterpreted: the sample was unusual, the comparator was unfair, performance will improve with tuning, the contract is already signed. With a rule agreed in advance by people who were not selling the tool, a negative result is a decision rather than a negotiation. The same applies after go-live: define in advance what level of degradation triggers suspension, and who has the authority to act on it without needing to reconvene a committee.

  • Write the stop criteria before results exist — afterwards, they become negotiable
  • Agree them with people who have no stake in the tool being adopted
  • Define the post-deployment degradation threshold that triggers suspension, and who may act
  • A negative validation result is a successful validation, not a failed project

Prefer slides, quizzes, and saved progress? Read this lesson in the library — free, no sign-up.